Lihakjn
Medical device for regenerative applications — Alfakjn proprietary configuration
Medical device
Premium
Owner
Regenerative
Lihakjn is a medical device for regenerative applications, with a configuration developed in-house by Alfakjn to support tissue regeneration processes in orthopaedic, physical medicine and rehabilitation, and specialist settings.
It fits within an approach that stimulates natural tissue repair processes rather than compensating for or suppressing them — a distinct clinical perspective, evaluated by highly qualified professionals based on scientific evidence and the quality of documentation.
-
Orthopaedics and physical medicine: conservative protocols to support post-traumatic or degenerative tissue repair.
-
Specialist surgery: support for regeneration in pre- or post-operative settings.
-
Sports medicine: regenerative approaches for professional and competitive athletes.
Specification
Value
Guy
Medical device for regenerative applications
Configuration
Proprietary, developed in-house by Alfakjn
Contexts
Orthopaedics, physical medicine and rehabilitation, specialist surgery, sports medicine
Specification
Value
Guy
Medical device for regenerative applications
Configuration
Proprietary, developed in-house by Alfakjn
Contexts
Orthopaedics, physical medicine and rehabilitation, specialist surgery, sports medicine
High-profile product, suitable for building relationships with leading professionals in the field of regenerative medicine. It is not a volume market, but one of positioning: the premium profile and technical documentation support the presentation both in academic contexts and in specialist clinics. It is the key to entering a premium segment with a credible and supported product.
Reference channel
Opinion leaders and centres of excellence; orthopaedics, physical and rehabilitation medicine, specialist surgery, sports medicine.
Support included
-
Comprehensive technical and scientific documentation for Lihakjn.
- Materials for the presentation to the specialist professional, with a focus on evidence and mechanism of action.
- Support with positioning towards opinion leaders and centres of excellence.
- Willingness to discuss approaches for markets with a high concentration of regenerative medicine professionals.

